- ►annals.org K Shan, AM Lincoff, JB Young - Annals of internal medicine, 1996 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Purpose: To review the current understanding of the clinical significance, ... Cited by 367 - Related articles - All 4 versions
LJ Steinherz, PG Steinherz, CT Tan, G Heller … - Jama, 1991 - Am Med Assoc OBJECTIVE.--To assess the cardiac status of long-term survivors of pediatric
malignancies who received chemotherapy, including anthracyclines. DESIGN AND
METHOD.-Patients were evaluated by echocardiogram from 4 to 20 years ... Cited by 487 - Related articles - All 3 versions
DD Von Hoff, MW Layard, P Basa, HL Davis … - Annals of internal medicine, 1979 - ncbi.nlm.nih.gov Potential risk factors responsible for development of doxorubicin-induced
congestive heart failure were examined through retrospective analysis of 4018
patient records. The overall incidence of drug-induced congestive heart ... Cited by 907 - Related articles
SE Lipshultz, SD Colan, RD Gelber, AR Perez … - New England Journal of Medicine, 1991 - content.nejm.org BACKGROUND. Cardiotoxicity is a recognized complication of doxorubicin therapy,
but the long-term effects of doxorubicin are not well documented. We therefore
assessed the cardiac status of 115 children who had been treated for acute ... Cited by 684 - Related articles - All 5 versions
IA Voutsadakis - J Hellenic Soc Haematol, 1998 - journals.indexcopernicus.com logo IndexCopernicus, Current language: English. ... Cited by 1 - Related articles - All 2 versions
SE Lipshultz, SR Lipsitz, SM Mone, AM … - The New England Journal of Medicine, 1995 - nejm.highwire.org Results All echocardiographic measurements were abnormal at follow-up a minimum
of two years after the end of therapy, with more frequent and severe
abnormalities in female patients. In a multivariate analysis, female sex ... Cited by 306 - Related articles - BL Direct - All 4 versions
- ►jcojournal.org [PDF] JP Krischer, S Epstein, DD Cuthbertson, AM … - Journal of Clinical Oncology, 1997 - jcojournal.org Purpose: To determine the incidence of clinical car- diotoxicity from
anthracycline chemotherapy in children with cancer and to identify associated
risk factors. Patients and Methods: The study population con- sisted of ... Cited by 171 - Related articles - BL Direct - All 6 versions
MT Meinardi, WTA Graaf, DJ Veldhuisen, JA … - Cancer treatment reviews, 1999 - Elsevier The use of anthracyclines, a group of potent anti-cancer agents incorporated
into the treatment of a wide variety of solid and haematological tumours, is
limited by its cardiotoxicity that can result in congestive heart failure ... Cited by 62 - Related articles - BL Direct - All 7 versions
A Giantris, L Abdurrahman, A Hinkle, B … - Critical Reviews in Oncology and Hematology, 1998 - Elsevier By the year 2010, it is predicted that one out of every 250 young adults in the
US aged 20-45 will be a survivor of childhood or adolescent cancer [1]. Thus,
the late sequelae of therapy will not only continue but will often be newly ... Cited by 69 - Related articles - All 4 versions
MA Grenier, SE Lipshultz - Seminars in oncology, 1998 - ncbi.nlm.nih.gov Anthracyclines, potent cytotoxic agents used to treat a broad spectrum of
malignancies, are limited in their use by an attendant risk of cardiotoxicity.
Malignancies affect all age ranges, and anthracyclines are used in all age ... Cited by 154 - Related articles - BL Direct - All 2 versions
